BioNexus Gene Lab Corp. (BGLC)
4.15
+0.01
(+0.24%)
USD |
NASDAQ |
Dec 16, 16:00
4.15
0.00 (0.00%)
After-Hours: 16:32
BioNexus Gene Lab Total Assets (Quarterly): 7.621M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Balchem Corp. | 1.661B |
| Innospec, Inc. | 1.799B |
| Alto Ingredients, Inc. | 388.47M |
| WD-40 Co. | 475.81M |
| General Enterprise Ventures, Inc. | 12.26M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 0.805M |
| Shareholders Equity (Quarterly) | 6.816M |
| Debt to Equity Ratio | 0.027 |
| Current Ratio | 8.299 |
| Net Debt Paydown Yield | 0.11% |